SEC Form 4 · accession 0001209191-17-035819
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stuart Essig
Director
Period of report
May 25, 2017
Accepted (ET)
May 26, 2017 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 25, 2017 | M | 73,780 | $17.45 | A | 2,077,475 | D | |
| Common Stock | May 25, 2017 | M | 135,000 | $17.45 | A | 2,212,475 | D | |
| Common Stock | May 25, 2017 | S | 135,000 | $49.90 | D | 2,077,475 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $17.45 | May 25, 2017 | M | 73,780 | D | — | Dec 18, 2017 | Common Stock | 73,780 | 135,000 | D |
| Non-Qualified Stock Option (right to buy)F2 | $17.45 | May 25, 2017 | M | 135,000 | D | — | Dec 18, 2017 | Common Stock | 135,000 | 0 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- F225% of the option grant vested on 12/18/2008 (the first anniversary of the grant date of 12/18/2007), and the remaining 75% vested monthly thereafter over 36 months.